Skip to main content
Erschienen in: Journal of Inherited Metabolic Disease 2/2013

01.03.2013 | Original Article

Intellectual and neurological functioning in Morquio syndrome (MPS IVa)

verfasst von: J. E. Davison, S. Kearney, J. Horton, K. Foster, A. C. Peet, C. J. Hendriksz

Erschienen in: Journal of Inherited Metabolic Disease | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

Mucopolysaccharidosis type IVa (MPS IVa, Morquio syndrome OMIM #253000) is a lysosomal storage disease caused by deficiency in N-acetylgalactosamine-6-sulfatase (GALNS, EC 3.1.6.4; encoded by GALNS gene at 16q24.3). Unlike other MPS disorders involving excessive heparan and dermatan sulfate, Morquio syndrome has not been associated with neurological involvement nor with intellectual impairment as this disorder of keratan sulfate has been described as a purely visceral and skeletal disorder. Neurocognitive assessment was undertaken of MPS IVa patients with age appropriate intellectual tests as well as a Child Behaviour Checklist as part of clinical follow up. Available neuroimaging studies (MRI and MR spectroscopy) were reviewed. Whilst more than half of the overall IQ scores fell in the average range, scores for 3/8 children fell below average. A number of behavioural problems were highlighted, including anxiety/depression, attention and somatic complaints. Subtle neuroimaging abnormalities were demonstrated in over half of the children. These findings present a challenge to existing assumptions about the nature of Morquio A syndrome. A hypothesis regarding the potential role of calcium signalling is explored.
Literatur
Zurück zum Zitat Capitao L, Sampaio A et al. (2011) Williams syndrome hypersociability: a neuropsychological study of the amygdala and prefrontal cortex hypotheses. Res Dev Disabil 32(3):1169–1179PubMedCrossRef Capitao L, Sampaio A et al. (2011) Williams syndrome hypersociability: a neuropsychological study of the amygdala and prefrontal cortex hypotheses. Res Dev Disabil 32(3):1169–1179PubMedCrossRef
Zurück zum Zitat Davison JE, Hendriksz CJ et al. (2010) Quantitative in vivo brain magnetic resonance spectroscopic monitoring of neurological involvement in mucopolysaccharidosis type II (Hunter Syndrome). J Inherit Metab Dis 33(6):819 Davison JE, Hendriksz CJ et al. (2010) Quantitative in vivo brain magnetic resonance spectroscopic monitoring of neurological involvement in mucopolysaccharidosis type II (Hunter Syndrome). J Inherit Metab Dis 33(6):819
Zurück zum Zitat Davison JE, Davies NP et al. (2011) MR spectroscopy-based brain metabolite profiling in propionic acidaemia: metabolic changes in the basal ganglia during acute decompensation and effect of liver transplantation. Orphanet J Rare Dis 6(1):19PubMedCrossRef Davison JE, Davies NP et al. (2011) MR spectroscopy-based brain metabolite profiling in propionic acidaemia: metabolic changes in the basal ganglia during acute decompensation and effect of liver transplantation. Orphanet J Rare Dis 6(1):19PubMedCrossRef
Zurück zum Zitat Dvorak-Ewell M, Wendt D et al. (2011) "Enzyme replacement in a human model of mucopolysaccharidosis IVA in vitro and its biodistribution in the cartilage of wild type mice.". PLoS ONE [Electron Resour] 5(8):e12194CrossRef Dvorak-Ewell M, Wendt D et al. (2011) "Enzyme replacement in a human model of mucopolysaccharidosis IVA in vitro and its biodistribution in the cartilage of wild type mice.". PLoS ONE [Electron Resour] 5(8):e12194CrossRef
Zurück zum Zitat Eisengart, J and Delaney K (2011) Age and Cognitive/adaptive function in MPS IIIA (Sanfilippo syndrome). 7th Annual World Symposium, Lysosomdal disease network Eisengart, J and Delaney K (2011) Age and Cognitive/adaptive function in MPS IIIA (Sanfilippo syndrome). 7th Annual World Symposium, Lysosomdal disease network
Zurück zum Zitat Gargus JJ (2010) Mitochondrial component of calcium signalling abnormality in autism. Autism: oxidative stress, inflammation and immune abnormalities. Chauhan A, Chauhan V and Brown T, CRC Press: 209–226 Gargus JJ (2010) Mitochondrial component of calcium signalling abnormality in autism. Autism: oxidative stress, inflammation and immune abnormalities. Chauhan A, Chauhan V and Brown T, CRC Press: 209–226
Zurück zum Zitat Holt JB, Poe MD et al. (2011) Natural progression of neurological disease in mucopolysaccharidosis type II. Pediatrics 127(5):e1258–e1265PubMedCrossRef Holt JB, Poe MD et al. (2011) Natural progression of neurological disease in mucopolysaccharidosis type II. Pediatrics 127(5):e1258–e1265PubMedCrossRef
Zurück zum Zitat Jawaid A, Schmolck H et al. (2008) Hypersociability in Williams syndrome: a role for the amygdala? Cogn Neuropsychiatry 13(4):338–342PubMedCrossRef Jawaid A, Schmolck H et al. (2008) Hypersociability in Williams syndrome: a role for the amygdala? Cogn Neuropsychiatry 13(4):338–342PubMedCrossRef
Zurück zum Zitat Jones W, Bellugi U et al. (2000) "II. Hypersociability in Williams Syndrome.". J Cogn Neurosci 12(Suppl 1):30–46PubMedCrossRef Jones W, Bellugi U et al. (2000) "II. Hypersociability in Williams Syndrome.". J Cogn Neurosci 12(Suppl 1):30–46PubMedCrossRef
Zurück zum Zitat Kantarci K, Jack CR et al. (2000) Regional metabolic patterns in mild cognitive impairment and Alzheimer’s disease: A 1H MRS study. Neurology 55(2):210–217PubMedCrossRef Kantarci K, Jack CR et al. (2000) Regional metabolic patterns in mild cognitive impairment and Alzheimer’s disease: A 1H MRS study. Neurology 55(2):210–217PubMedCrossRef
Zurück zum Zitat Koto A, Horwitz AL et al. (1978) The morquio syndrome: Neuropathology and biochemistry. Ann Neurol 4(1):26–36PubMedCrossRef Koto A, Horwitz AL et al. (1978) The morquio syndrome: Neuropathology and biochemistry. Ann Neurol 4(1):26–36PubMedCrossRef
Zurück zum Zitat Kumar YV, Narayanan HS et al. (1979) A report of two cases of Morquio’s syndrome associated with mental retardation. Aust J Ment Retard 5(8):319–321 Kumar YV, Narayanan HS et al. (1979) A report of two cases of Morquio’s syndrome associated with mental retardation. Aust J Ment Retard 5(8):319–321
Zurück zum Zitat Lloyd-Evans E, Platt FM (2011) Lysosomal Ca(2+) homeostasis: role in pathogenesis of lysosomal storage diseases. Cell Calcium 50(2):200–205PubMedCrossRef Lloyd-Evans E, Platt FM (2011) Lysosomal Ca(2+) homeostasis: role in pathogenesis of lysosomal storage diseases. Cell Calcium 50(2):200–205PubMedCrossRef
Zurück zum Zitat Miller B, Sheppard AM et al. (1997) Developmental expression of keratan sulfate-like immunoreactivity distinguishes thalamic nuclei and cortical domains. J Comp Neurol 380(4):533–552PubMedCrossRef Miller B, Sheppard AM et al. (1997) Developmental expression of keratan sulfate-like immunoreactivity distinguishes thalamic nuclei and cortical domains. J Comp Neurol 380(4):533–552PubMedCrossRef
Zurück zum Zitat Montaño AM, Yamagishi A et al. (2000) "The mouse N-acetylgalactosamine-6-sulfate sulfatase (Galns) gene: cDNA isolation, genomic characterization, chromosomal assignment and analysis of the 5′-flanking region.". Biochimica et Biophysica Acta (BBA) - Mol Basis Dis 1500(3):323–334CrossRef Montaño AM, Yamagishi A et al. (2000) "The mouse N-acetylgalactosamine-6-sulfate sulfatase (Galns) gene: cDNA isolation, genomic characterization, chromosomal assignment and analysis of the 5′-flanking region.". Biochimica et Biophysica Acta (BBA) - Mol Basis Dis 1500(3):323–334CrossRef
Zurück zum Zitat Northover H, Cowie RA et al. (1996) Mucopolysaccharidosis type IVA (Morquio syndrome): a clinical review. J Inherit Metab Dis 19(3):357–365PubMedCrossRef Northover H, Cowie RA et al. (1996) Mucopolysaccharidosis type IVA (Morquio syndrome): a clinical review. J Inherit Metab Dis 19(3):357–365PubMedCrossRef
Zurück zum Zitat Ong DS, Mu TW et al. (2010) Endoplasmic reticulum Ca2+ increases enhance mutant glucocerebrosidase proteostasis. Nat Chem Biol 6(6):424–432PubMedCrossRef Ong DS, Mu TW et al. (2010) Endoplasmic reticulum Ca2+ increases enhance mutant glucocerebrosidase proteostasis. Nat Chem Biol 6(6):424–432PubMedCrossRef
Zurück zum Zitat Potegal, M and Yund B (2011) Comparison of social/emotional function in children with MPS I and MPS III: Interim Report. 7th Annual World Symposium, Lysosomdal disease network Potegal, M and Yund B (2011) Comparison of social/emotional function in children with MPS I and MPS III: Interim Report. 7th Annual World Symposium, Lysosomdal disease network
Zurück zum Zitat Sasaki T, Garant PR (1986) Ultracytochemical demonstration of ATP-dependent calcium pump in ameloblasts of rat incisor enamel organ. Calcif Tissue Int 39(2):86–96PubMedCrossRef Sasaki T, Garant PR (1986) Ultracytochemical demonstration of ATP-dependent calcium pump in ameloblasts of rat incisor enamel organ. Calcif Tissue Int 39(2):86–96PubMedCrossRef
Zurück zum Zitat Sasaki T, Garant PR (1987) Calmodulin blocker inhibits Ca++ − ATPase activity in secretory ameloblast of rat incisor. Cell Tissue Res 248(1):103–110PubMedCrossRef Sasaki T, Garant PR (1987) Calmodulin blocker inhibits Ca++ − ATPase activity in secretory ameloblast of rat incisor. Cell Tissue Res 248(1):103–110PubMedCrossRef
Zurück zum Zitat Singh J, Di Ferrante N et al. (1976) N-acetylgalactosamine-6-sulfate sulfatase in man. Absence of the enzyme in Morquio disease. J Clin Invest 57(4):1036–1040PubMedCrossRef Singh J, Di Ferrante N et al. (1976) N-acetylgalactosamine-6-sulfate sulfatase in man. Absence of the enzyme in Morquio disease. J Clin Invest 57(4):1036–1040PubMedCrossRef
Zurück zum Zitat Tessitore A, Pirozzi M et al. (2009) Abnormal autophagy, ubiquitination, inflammation and apoptosis are dependent upon lysosomal storage and are useful biomarkers of mucopolysaccharidosis VI. Pathogenetics 2(1):4PubMedCrossRef Tessitore A, Pirozzi M et al. (2009) Abnormal autophagy, ubiquitination, inflammation and apoptosis are dependent upon lysosomal storage and are useful biomarkers of mucopolysaccharidosis VI. Pathogenetics 2(1):4PubMedCrossRef
Zurück zum Zitat Tomatsu S, Orii KO et al. (2003) Mouse model of N-acetylgalactosamine-6-sulfate sulfatase deficiency (Galns−/−) produced by targeted disruption of the gene defective in Morquio A disease. Hum Mol Genet 12(24):3349–3358PubMedCrossRef Tomatsu S, Orii KO et al. (2003) Mouse model of N-acetylgalactosamine-6-sulfate sulfatase deficiency (Galns−/−) produced by targeted disruption of the gene defective in Morquio A disease. Hum Mol Genet 12(24):3349–3358PubMedCrossRef
Zurück zum Zitat Tomatsu S, Montano AM et al. (2008) Enzyme replacement therapy in a murine model of Morquio A syndrome. Hum Mol Genet 17(6):815–824PubMedCrossRef Tomatsu S, Montano AM et al. (2008) Enzyme replacement therapy in a murine model of Morquio A syndrome. Hum Mol Genet 17(6):815–824PubMedCrossRef
Zurück zum Zitat Vicencio JM, Lavandero S et al. (2010) Ca2+, autophagy and protein degradation: thrown off balance in neurodegenerative disease. Cell Calcium 47(2):112–121PubMedCrossRef Vicencio JM, Lavandero S et al. (2010) Ca2+, autophagy and protein degradation: thrown off balance in neurodegenerative disease. Cell Calcium 47(2):112–121PubMedCrossRef
Zurück zum Zitat Vitner EB, Platt FM et al. (2010) Common and uncommon pathogenic cascades in lysosomal storage diseases. J Biol Chem 285(27):20423–20427PubMedCrossRef Vitner EB, Platt FM et al. (2010) Common and uncommon pathogenic cascades in lysosomal storage diseases. J Biol Chem 285(27):20423–20427PubMedCrossRef
Zurück zum Zitat Wang F, Agnello G et al. (2011) "Ca2+ homeostasis modulation enhances the amenability of L444P glucosylcerebrosidase to proteostasis regulation in patient-derived fibroblasts.". ACS Chem Biol [Electron Resour] 6(2):158–168CrossRef Wang F, Agnello G et al. (2011) "Ca2+ homeostasis modulation enhances the amenability of L444P glucosylcerebrosidase to proteostasis regulation in patient-derived fibroblasts.". ACS Chem Biol [Electron Resour] 6(2):158–168CrossRef
Zurück zum Zitat Zhang H, Uchimura K et al. (2006) Brain keratan sulfate and glial scar formation. Ann N Y Acad Sci 1086:81–90PubMedCrossRef Zhang H, Uchimura K et al. (2006) Brain keratan sulfate and glial scar formation. Ann N Y Acad Sci 1086:81–90PubMedCrossRef
Metadaten
Titel
Intellectual and neurological functioning in Morquio syndrome (MPS IVa)
verfasst von
J. E. Davison
S. Kearney
J. Horton
K. Foster
A. C. Peet
C. J. Hendriksz
Publikationsdatum
01.03.2013
Verlag
Springer Netherlands
Erschienen in
Journal of Inherited Metabolic Disease / Ausgabe 2/2013
Print ISSN: 0141-8955
Elektronische ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-011-9430-5

Weitere Artikel der Ausgabe 2/2013

Journal of Inherited Metabolic Disease 2/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.